Medicrea (EPA:ALMED) announced that it is engaged in active discussions with potential strategic partners in the U.S. spine industry as it seeks to execute an agreement resulting in a company takeover, partnerships or distribution agreements. The company said that leading U.S. groups have made regular approaches to share industry developments and review potential strategic partnerships around […]
Medicrea Group
FDA clears pediatric spine implants from Medicrea
Medicrea (EPA:ALMED) said today it won FDA 510(k) clearances for is Pass XS posterior fixation and LigaPass XS band connector components designed for pediatric spinal deformities in small stature patients. The New York City and Lyon, France-based company said it worked with a team of pediatric spinal surgeons to develop the low profile implants specifically designed […]
Medicrea touts FDA win for LigaPass screw-free spinal implant | Regulatory Roundup
Biomet sees slight sales increase as losses widen | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days: